DVT needs to be more accurately categorized ... Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical ...

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Prior to the introduction of intravenous heparin, surgical thrombectomy was the only effective means for treating a symptomatic lower extremity DVT, [21] but the reported outcomes of open surgical ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for ...

Background Endovascular treatment (EVT) is a well-established approach for acute ischemic stroke. Whether bridging intravenous thrombolysis (IVT) before EVT confers any benefits remains uncertain. The ...

virginia.edu Background Cerebral venous sinus thrombosis (CVST) is an uncommon form of stroke that, when severe, can be a therapeutic challenge. Endovascular mechanical thrombectomy (EMT) techniques ...

Inari Medical (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an ...

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...